01/07/2025

Elevation Advisors LLP (“Elevation”) is pleased to announce an update on activities and transactions completed in the first half of 2025 by Elevation Healthcare Properties (“EHP”), a healthcare real estate fund advised by Elevation. 

Transactions & Developments: During H1 2025, EHP added a new home to the portfolio and construction progressed on 7 additional development sites.  Key activities include:

ESG: EHP has a robust and comprehensive ESG strategy in place to deliver targeted environmental sustainability and positive social outcomes. Initiatives delivered during H1 2025 include:

James Giles, Investment Director at Elevation said: “EHP seeks to address the structural undersupply of elderly care beds in the U.K. and delivers modern, high-quality care communities, designed to meet increasing environmental standards.  We are delighted to announce an additional home to the portfolio and provide an update on the progress of our eight current developments which will collectively increase the UK care home bed supply by c.542 beds.  This progress demonstrates the stable and resilient growth of EHP and its successful alignment with the needs of investors and stakeholders.  We are delighted with the continued success of EHP and look forward to realising our 2025 ambitions in the second half of the year.”

< Back to news

Follow us on LinkedIn >

Disclaimer
This press release is issued by Elevation Advisors LLP, which is authorised and regulated by the Financial Conduct Authority. The information contained herein is provided for informational purposes only and does not constitute investment advice, an offer to buy or sell any financial instrument, or a solicitation of any kind. Past performance is not a reliable indicator of future results. Any forward-looking statements or projections are based on current assumptions and subject to risks and uncertainties that may cause actual outcomes to differ materially. This communication is intended solely for professional clients and eligible counterparties as defined by the FCA. It is not directed at retail clients and should not be relied upon by any person who does not meet the criteria for professional client classification. Investments may involve significant risk, including the potential loss of capital. Recipients should seek independent financial advice before making any investment decisions. While reasonable care has been taken to ensure the accuracy of the information provided, Elevation Advisors LLP makes no representation or warranty as to its completeness or reliability and accepts no liability for any loss arising from reliance on it.